Cancer Predisposition Tests May Be Possible From New Research

5:02 p.m. Feb. 23, 2011

A group of researchers led by scientists from the Virginia Bioinformatics Institute (VBI) at Virginia Tech have developed a new technology that detects distinct genetic changes differentiating cancer patients from healthy individuals and could serve as a future cancer predisposition test. The multidisciplinary team, which includes researchers from the University of Texas Southwestern...

read more

Liver Cancer Treatment Being Advanced With Nanotechnology

4:59 p.m. Feb. 23, 2011

Nanotechnology may open a new door on the treatment of liver cancer, according to a team of Penn State College of Medicine researchers. They used molecular-sized bubbles filled with chemotherapy drugs to prevent cell growth and initiate cell death in test tubes and mice. Researchers evaluated the use of molecular-sized bubbles filled with C6-ceramide, called cerasomes, as an anti-cancer...

read more

Breast Cancer Prevention Needs Much Higher Vitamin D Intake

2:28 p.m. Feb. 22, 2011

Researchers at the University of California, San Diego School of Medicine and Creighton University School of Medicine in Omaha have reported that markedly higher intake of vitamin D is needed to reach blood levels that can prevent or markedly cut the incidence of breast cancer and several other major diseases than had been originally thought. The findings are published February 21 in the...

read more

Using Genomics To Better Understand Childhood Cancers

11:24 a.m. Feb. 22, 2011

Vancouver, BC— In a project supported by Genome BC, a Vancouver pediatric pathologist at the BC Cancer Agency/University of British Columbia is leading the team that will explore the genomes (DNA) of four of the most challenging childhood cancers known. Dr. Poul Sorensen and his colleagues in the Canadian Pediatric Cancer Genome Consortium hope to find the link between primary and...

read more

New Compound For Controlling Cholesterol May Also Kill Breast Cancer Cells

10:19 a.m. Feb. 22, 2011

COLUMBIA, Mo. – A University of Missouri researcher believes there could be a new drug compound that could kill breast cancer cells. The compound might also help with controlling cholesterol. Salman Hyder, the Zalk Endowed Professor in Tumor Angiogenesis and professor of biomedical sciences in the College of Veterinary Medicine and the Dalton Cardiovascular Research Center, and his...

read more